Cancer therapeutics–related cardiac dysfunction was defined as a decrease in the left ventricular ejection fraction of >10 percentage points, to a value <53%, in a recent expert consensus document (1). Clinically, early prediction of cardiotoxicity in patients receiving chemotherapy may be useful for defining an optimal strategy to prevent ventricular functional impairment.
- letter to the editor
- short communication
- Chemotherapy-Treated Patients
- Prediction of Cardiotoxicity
- Myocardial Strain Imaging